Worldwide Clinical Trials, a significant contract research organization, has appointed Dr. Jayaprakash (JP) Kotha as Vice President, Bioanalytical. Dr. Kotha, with a rich background in diagnostic and research labs, will lead the Bioanalytical Center of Excellence in Austin, Texas. This facility, opened in 2022, is a modern 60,000 square foot lab dedicated to small and large molecule bioanalysis, PK/PD analysis, and genotyping expertise and includes an additional 15,000 square foot space additionally for large molecule bioanalytical testing. Dr. Kotha’s expertise is expected to enhance Worldwide’s ability to offer comprehensive bioanalytical services and support the development of new drugs and treatments. Mike Mencer, Executive Vice President and General Manager, Early Phase at Worldwide, expressed confidence in Dr. Kotha’s experience to meet customer needs and contribute significantly to the business.

Source link: http://www.businesswire.com/news/home/20231129451629/en/JP-Kotha-Appointed-Vice-President-Bioanalytical-at-Worldwide-Clinical-Trials

author avatar
Ferry Darma
Ferry Darma is Director of Media Relations at The Clinical Trial Vanguard. Ferry, a computer data scientist, focuses on the latest clinical trial industry news and trends.